chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Reactions; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Reactions) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Reactions). At the time of the report, ADVERSE EVENT (Reactions) outcome was unknown.            Treatment information not provided. Concomitant mediations were not provided.   This case was linked to MOD-2021-025474 (Patient Link).
Child developed hives all over the trunk. Blistering type. Happened during two separate vaccination appointments. The second time was worse. Believed to be an allergy to one of the vaccines. Child stopped speaking completely within a 1-2 week period. Before vaccination was developing speech at the appropriate rate. Did not resume any speaking until 3 1/2 years old after intensive speech therapy. Referred to specialists and behavioral clinic. Child has SPD. Child has "unknown anxiety". Child concurrently treated for difficulty breathing--asthma diagnosis. Child has ADHD. Multiple vaccines at once, multiple times--unsure of lot numbers or types.
symptoms include aching, tiredness, fever, and sore throat; Ann itchy red splotchy blister-like rashes on head(in hair), forehead, side and front of abdomen, and legs. Treatment analgesic + antihistamines.
About 45 min following flu shot, client noted arm numbness and tingling in fingers in that arm. Client then stated she was dx with Lymes Disease and wonders if it had an adverse reaction due to illness.
A report was received from French R agency on 01/10/2002, concerning a 5 year old female pt who experienced asthma crisis resolution in hospitalizations 5 days after receiving the second dose injection of fluvirin on 10/27/2001; the first having been on 10/03/2001. The pt had a medical history of cyctic fibrosis. During the night of 11/01/2001-11/02/2001, the pt experienced on asthma crisis. The pt was hospitalized in the Pediatric dept with fever (37.8 deg. C) and congestion. The pt recovered without sequelae following IV antibiotic and corticosteroid treatment.
Feeling lightheaded about 15 minutes after vaccination. Denies any other symptoms No swelling, hives, or respiratory symptoms noted. Patient calm, speaking voice monitored. Dr. called & interviewed patient. Patient observed additional 15 min & reported sx improved before leaving. 38 y/o F who c/o dizziness after vaccination No other complaints Exam - unremarkable Plan - home with monitoring Unlikely to be allergic Rxn
Information has been received from a female consumer who stated that her uncle received on an unspecified date an unspecified MUMPSVAX (manufacturer unknown) during an outbreak situation and became deaf. As of 05-JAN-2009 the outcome of the patient was unknown. Upon internal review, deafness was considered to be an Other Important Medical Event. Additional information is not expected.
In May of 2023, I woke up in the morning and I noticed I had a floater in my left eye. I looked at the wall and thought I saw a dark spot on the wall. I consulted my eye doctor and the did some imaging. At the time, he did not see any damage to my retina.
I started experiencing fatigue, extreme thirst and had the feeling of constant urination. On 05/20/2021 I reached out to my health care provider and was told that my blood sugar levels have been elevated.
Information has been received from another manufacturer and was assignment manufacturer report number HQWYE497823FEB05. It was reported that a female patient was vaccinated, on 11/20/03, with a dose of MMR. On 3/24/04 the patient experienced autism. It was reported that the patient has not recovered. The patient's vaccination history included a dose of varicella virus vaccine live on 8/21/03 and a dose of hepatitis B virus vaccine on 10/8/02. Autism was considered to be an other important medical event (OMIC). Additional information has been requested.
About 3 days after the first dose I had slight numbness in my left leg and foot. Note: before I walked 2 miles per day, I stopped walking because foot and leg numbness.  About 2 weeks after dose 2 I had extreme numbness and weakness in both legs and could hardly walk. I was about to go to ER but made a appointment for 6/1/2021 with Dr   he said the pain was nerve damge from covid 19 vaccination and that the nerves should rebuilt themselves.  As of today 6/07/2021 I still have numbness and weakness in both legs and feet especially in my left leg.
Pt developed extreme fatigue. Felt tired and sleepy. BP 170/72, HR 67, O2sat 97% RA. Reported having double vision. Denied chest pain, sob, palpitations, headache, dizziness. Sent to ER via w/c.
Headache, muscle pain, sore throat, fever, sinus pressure, difficulty focusing eyes, fatigue.  Memorable symptoms began on Feb. 19th, the worst day was Feb. 20th, when I was unable to complete my usual daily activities.  My symptoms have begun to improve today, Feb 23rd. On Dec. 17th, 2020 I was diagnosed with COVID19.
PFIZER COVID-19 VACCINE (EUA) Starting at 5pm on 4/29:  Swelling, soreness, redness and heat at injection site and 3" diameter around it. Persisted for 2 days  Starting at 2am on 4/30: Fever Chills Headache Skin sensitivity (all over body) Joint aches Persisted for 24 hours  Starting around 4pm on 4/30: Swollen and painful lymph node in left armpit. Persisted for 2.5 days.
This spontaneous report as received from a health professional refers to unspecified number of patients of unknown age and gender. The patient's pertinent medical history and concomitant medications were not reported. On an unknown date, the patients were vaccinated with improperly stored VARIVAX (Merck) (lot #, expiry date, dose and route of administration were not reported). No adverse effects were reported. Additional information has been requested.
I've experienced 3 very bad and long lasting colds since receiving the bivalent shot. 2 required visits to Expresscare and I am still fighting sinus and cough problems from the 3rd cold which began on Feb 17, 2023.
pt recvd vax & w/in hrs exp hives; An ER or MD visit was required & pt was treated w/an antihistamine;
Information has been received from a health professional concerning a fourth grade 10-year-old male who on 01/12/1996 was vaccinated with Varicella virus vaccine live. On 03/01/2001, the pt experienced Varicella. Unspecified medical attention was sought.  Follow up information has been received from a registered nurse who states the mother called the office then the physician saw the child to confirm the diagnosis of  "breakthrough case of chickenpox". The child has recovered.
Dose 1: Pain and swelling at injection site and swelling of lymphoid under same arm for 1.5 weeks after injection. Dose 2: 11 hours after injection, woke up with fever, nausea, body aches.  Nausea turned into vomiting for the next 12 hours.  Couldn't stand up without nausea.  The fever, nausea, and body aches lasted for 72 hours.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 65-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 14Oct2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 65 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Cancer" (unspecified if ongoing); "antiphospholipid syndrome" (unspecified if ongoing); "Allergic Rhinitis" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Lipitor, reaction(s): "Known allergies: Lipitor", notes: Known allergies: Lipitor. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: It was reported other medication in 2weeks reported as yes; the Paxlovid treatment start date: 03Jan2023 and stop date: 08Jan2023. Adverse event: Recurrent symptoms of Covid especially cough, post nasal drip, Rhinorrhea, and myalgias.   The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Based on available information and temporal association the causal role of suspect product cannot be excluded for reported events Case will be reviewed on receipt of FU information.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021 at 9:56 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 17-Feb-2021 at 9:56 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 71.22 for dose administered on 17-Feb-2021.   No concomitant medications were reported.   Batch number 022M20A underwent temperature excursion on 17-Feb-2021 with temperature 22 degrees Fahrenheit from 09:00 AM to 10:00 AM. This vial was moved to fridge on 11-Feb-2021 and beyond use date for the vial was reported as 10-Mar-2021. Product moved to clinic on 17-Feb-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a temperature monitor at every hour. No treatment medications were reported.
not feeling well; she mentions feeling lethargic; she can barely talk; sores in mouth; red swollen lump under her eye and on the side of her nose,symptoms have gotten progressively worse and today is the worst day of them all; arms and hands are going numb on and off; muscle aches; exhausted; This spontaneous case was reported by a patient and describes the occurrence of MALAISE (not feeling well), LETHARGY (she mentions feeling lethargic), SPEECH DISORDER (she can barely talk), ORAL PAIN (sores in mouth) and SKIN MASS (red swollen lump under her eye and on the side of her nose,symptoms have gotten progressively worse and today is the worst day of them all) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A, 045A21A and 017B22A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sulfonamide allergy, Allergy to antibiotic, Penicillin allergy, Allergy to antibiotic, Latex allergy and Drug allergy.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Jul-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Jul-2022, the patient experienced MALAISE (not feeling well), LETHARGY (she mentions feeling lethargic), SPEECH DISORDER (she can barely talk), ORAL PAIN (sores in mouth), SKIN MASS (red swollen lump under her eye and on the side of her nose,symptoms have gotten progressively worse and today is the worst day of them all), HYPOAESTHESIA (arms and hands are going numb on and off), MYALGIA (muscle aches) and FATIGUE (exhausted). The patient was treated with NAPROXEN at an unspecified dose and frequency and OXYCODONE at an unspecified dose and frequency. At the time of the report, MALAISE (not feeling well), LETHARGY (she mentions feeling lethargic), SPEECH DISORDER (she can barely talk), ORAL PAIN (sores in mouth), SKIN MASS (red swollen lump under her eye and on the side of her nose,symptoms have gotten progressively worse and today is the worst day of them all), HYPOAESTHESIA (arms and hands are going numb on and off), MYALGIA (muscle aches) and FATIGUE (exhausted) had not resolved.            The patient did not ever have COVID + test or diagnosis.  Patient did not receive other vaccines within 1 month prior to Moderna COVID-19 vaccine.  The AE did not cause patient to seek medical care (office visit, Urgent care, ER, hospitalized).  The patient did not experience a similar event in the past. The symptoms have worsened.  She refers having medications for chronic illnesses but prefers not to share that.
Extreme soreness. Redness. Neck pain. Shooting pain in neck and back of head.
Patient reports receiving second dose of COVID vaccine on Saturday (Pfizer) and that night experienced fever and chills. When patient awoke in the morning he reports neck stiffness and left sided chest pain. The neck stiffness has since mostly resolved although chest pain has been getting worse. Patient reports it is localized, sharp, non radiating, constant, 6/10 in severity and exertional. pt admitted at Hospital ++ marked troponin leak and  cardiac cath which revealed non obstructive CAD, elevated LVEDP (30) and transferred to another facility . Pt started on milrinone drip and had a endomycocardial biopsy on 4/22/21 :  no lymphocytic myocarditis  pt discahrgedon 4/23 with outpatient fu and   metoprolol succinate and spironolactone for 3 months if tolerated to minimize myocardial injury from resultant inflammation + cats at home
10AUG98 h/a, fatigue;11AUG98 -13AUG98 same;14AUG98 saw MD had varicella like rash upper torso, face-ear pain, etc;tx med;
Immune mediated hemolytic anemia - Hgb 4 => 4 days following administration of DTaP. 8/7/08-records received-for DOS 6/16-6/26/08-DC DX: Autoimmune hemolytic anemia. C/O vomiting rhinorrhea, cough, sleepy limp. Severe anemia. Two days prior began having mild emesis, fevers, and fatigue, pale and tired.
Patient started having numbness in her left hand 15 minutes after injection. Numbness has continued for the last 8 days.
Said arm was severely inflamed and continued for over 3 weeks (almost went to ER); says blood pressure is still now out of whack due to reaction.
Lymphedema right axilla with radiating pain. History of conjunctival hemorrhages previously.
This study case was received from the investigator on 29 August 2012. A male subject experienced heart palpitations on 23 August 2012, eight days after the subject had received on 15 August 2012 the following vaccines: ACAM2000 (lot number, route and site of administration not reported), an injection of TYPHOID VACCINE (lot number, route and site of administration not reported) and an injection of ANTHRAX VACCINE (lot number, route and site of administration not reported). The subject also went to the dentist on 22 August 2012 for a filling which caused him pain in his tooth. He took ibuprofen for that on the day only. The subject had an ECG done on 24 August 2012 which was normal. Rapid troponin on 24 August 2012 was also normal. The subject had no past medical history and took no concomitant medications. No further information was available at the time of the report. The subject's outcome was recovered on 23 August 2012. According to the investigator, palpitations were possibly related to the trial product. Documents held by sender: none.
27 y/o female reported to the ER for atypical chest pain on 5/2/2021. Clinical concern for CAD was low, however there was some concern for myocarditis due to chest pain and ECG findings that began one day after 2nd dose of Pfizer vaccine. Patient was referred to an outpatient cardiologist to perform cardiac MRI to assess for subclinical myocarditis.  Follow up with PCP: 5/10, cardiac f/u in June.  Tests performed: ECG 5/3, Stress test 5/3, myocardial perfusion imaging
ACCORDING TO THE PATIENT, SHE STARTED ITCHING, SCRATCHING, AND DEVELOPED FEW BLISTERRS IN THIGH NEXT DAY OF VACCINATION WHICH LASTED FOR 3 DAYS. THERE WAS NO FEVER. PATIENT TOOK ACYCLOVIR 100MG BID HERSELF (FROM LAST TIME LEFTOVER) WITHOUT CONSULTING TO HER DOCTOR THIS TIME.
Imms done on 1/23/2020. On 1/31/2020, mom noted a red spot on his leg where he got the shot. Initially no induration or warmth. Did not seem painful. On 2/2/2020 noticed it was hard and warm, temp 99.5. Office visit on 2/3/2020. Mom states it looks better today - no longer warm and not as hard.
6 days after the second moderna Covid shot, she developed a rash that is both hot to the touch and itchy. Has had it for two days so far. Not taking any medication for these symptoms.
Misery. At 12 hrs after, fatigue, moderate headache (lasted about 6 hours), fever of 100 degrees and chills for a couple hours; progressed to all over severe body aches for several hours. All symptoms cleared within 12 hours.
At 1038 Client started with flushing of the face and started feeling as though her throat was swelling. She took an allergy pill that she had brought with her in case of a reaction. She carries an epi pen but stated that she has never had to use it. She stated that she had a similar reaction to receiving a flu vaccine 25 years ago (flushing, itching and swelling).  She was assessed by EMS staff that was on site.
Breakthrough case admission after 4 vaccines  Pfizer 1/26/21 Lot# EL9264;  Pfizer 2/16/21 lot# EN6200;  Pfizer 9/14/21 lot# Er8732;  Pfizer 4/18/22 lot# FK9894
People have died from the Moderna vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DEATH (People have died from the Moderna vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history per source document).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Death occurred on an unknown date The cause of death was not reported. It is unknown if an autopsy was performed.            No concomitant products were reported. No treatment information provided.  Company comment: This is a case of sudden death in a patient with unknown age and gender and with unknown past medical history who died in unknown days after receiving a dose of the vaccine. Very limited information has been provided at this time.; Sender's Comments: This is a case of sudden death in a patient with unknown age and gender and with unknown past medical history who died in unknown days after receiving a dose of the vaccine. Very limited information has been provided at this time.; Reported Cause(s) of Death: People have died from the Moderna vaccine
6/30 - Small dark bump around right ribcage. 7/2 - Bumps became overlapping welts. - Saw Dr. - Said it looked like shingles. 7/10 - Saw Dr. began aggressive treatment.
Patient got shingles 3 days after vaccination on R face.  severe sx- went to ER.  I noticed it is not listed as an adverse effect on LExapro, but there are case reports.
Fully vaccinated patient (Moderna dose #1 2/2/21, dose #2 3/10/21) began experiencing COVID symptoms 7/30/21. Symptoms included shortness of breath, chills, myalgia, and sore throat. Admitted to Medical Center 8/7/21. Patient still admitted on hospital day 3.
Sore achy joints that started upon waking and got progressively worse through the day, headache, exhaustion, fever of 100.5, chills, nausea & loss of appetite.  Treated with alternating ibuprofen & acetaminophen.  All effects were gone within 24 hours of onset.
This spontaneous report as received from a medical assistant refers to unknown number of patients of unknown age. The medical assistant reported on an unknown date, unknown number of patients were vaccinated with a dose of M-M-R II (lot #, dose/frequency and route unknown) which were improperly stored. No adverse effects reported. This is one of three reports (MARRS# 1403USA008050, 1403USA009144) received from the same source. Additional information has been requested.
Narrative: A 69 year old male presents to ER with complaint of cough, congestion, and difficulty with urination. Patient presents with worsening symptoms for the past 4 days. Patient also has a note with him that was written by his wife. Since Monday, patient reports worsening cough productive of clear sputum, congestion, sore throat, shortness of breath. Patient is on 3 L of oxygen at baseline and reports significant shortness of breath with walking just 15 feet, which he states has been ongoing for the past year. In addition, patient reports difficulty with urination. He states that he only dribbles out small amounts of urine and does not feel like ne IS ever emptying Ins bladder. Of note patient with multiple comorbidities including HFpEF (EF 55-60%), small pericardial effusion, multiple myeloma (diagnosed 2018 off tx since 2019); CKD IV, chronic venous stasis and LE ulcers, DM2, HTN, HLD, CVA, Renal Cell carcinoma s/p right nephrectomy. On 9/6, patient displayed worsening respiratory distress with requirement of Oxymask. Patient was initially transferred to the PCU for HHFNC and placed on 60L 600 0 without notable improvement. Patient was seen by Renal who consented tor tunnel catheter due to poor renal mncüon. With Ins poor renal function and increase oxygen requirements that patient was deemed unstable for Medicine floor and transferred to the MICU for further medical management. Following admission to the MICU pt expressed wishes to transition to comfort measures only. Wife was able to visit and with full decision making capacity the patient opted for CMO. Palliative care was consulted, pt known to them. He was started on comfort pain ativan, bowel regimen. As pt was about to be transferred to medicine floor he became apneic and bradycardic and passed at 10:45am.